Skip to main contentSkip to navigation
Sirius Investors
Mediclinic International plc

Mediclinic International plc

ANHGY
OTCHealthcare

Mediclinic International plc (ANHGY) Investment Research Dashboard

About Mediclinic International plc (ANHGY) stock analysis

Get live ANHGY stock price $5.49, comprehensive Mediclinic International plc stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time ANHGY stock data and investment insights.

5.49
0.00%Today
Market Cap
4.05B
Volume
1
52W High
5.58
52W Low
4.62

Loading chart data...

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Mediclinic International plc, through its various group entities, manages and operates private healthcare facilities, delivering comprehensive, specialist-driven, and diverse medical care under the Mediclinic and Hirslanden brand names. Its extensive...

Company Information

CEO
Carel Aron van der Merwe D.A. M.B.Ch.B.
Sector
Healthcare
Industry
Medical - Care Facilities
Employees
33683

Contact Information

Address
25 Du Toit Street
Country
ZA

Investment Analysis & Business Insights

Healthcare
Medical - Care Facilities

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 23.9)

Lower volatility stock (Beta: 0.39) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Mediclinic International plc shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Mediclinic International plc
  • Investors should consider how Mediclinic International plc fits within their overall portfolio allocation

Market Cap

4.05B

P/E Ratio (TTM)

23.87

Beta

0.39

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

78/100 ⭐⭐⭐⭐⭐

Overall
+0.7%
NYSE
+0.6%
NASDAQ
+0.7%
Sector1D1W1MP/EScore
Financial Services+2.2%+3.1%+4.3%19.3
98/100⭐⭐⭐⭐⭐
Healthcare+0.7%+1.3%+1.6%24.1
78/100⭐⭐⭐⭐⭐
Communication Services+1.4%-0.7%+2.9%22.2
74/100⭐⭐⭐⭐⭐
Consumer Defensive-0.2%+1.8%+0.7%29.8
64/100⭐⭐⭐⭐
Basic Materials+0.4%+1.2%-0.2%25.2
61/100⭐⭐⭐⭐
Real Estate-0.5%+0.0%-2.4%29.2
46/100⭐⭐⭐
Energy-2.1%-3.7%-4.1%19.1
39/100⭐⭐
Utilities-1.0%+0.0%-4.4%26.8
35/100⭐⭐
Industrials+0.6%+0.4%-9.9%30.1
23/100
Consumer Cyclical+0.5%-1.5%-5.8%43.0
18/100
Technology+0.6%-1.6%-7.2%40.7
15/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.